Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

  • Paxton Loke
  • , Kuang Chih Hsiao
  • , Adriana Chebar Lozinsky
  • , Sarah E. Ashley
  • , Melanie Lloyd
  • , Sigrid Pitkin
  • , Christine Jean Axelrad
  • , Kaushala S. Jayawardana
  • , Dean Tey
  • , Ee Lyn Su
  • , Marnie Robinson
  • , Agnes S.Y. Leung
  • , Audrey Dunn Galvin
  • , Mimi L.K. Tang

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)806-811
Number of pages6
JournalClinical and Experimental Allergy
Volume52
Issue number6
DOIs
Publication statusPublished - Jun 2022

Keywords

  • health-related quality of life
  • oral immunotherapy
  • Peanut allergy
  • probiotic and peanut oral immunotherapy
  • sustained unresponsiveness

Cite this